Table 3

Reported adverse effects by study group

Topiramate group

N = 30 (%)

Control group

N = 55 (%)


Dizziness

6 (20.0)

4 (7.2)


Somnolence

7 (23.3)

3 (5.4)*


Nervousness

2 (6.6)

7 (12.7)


Numbness/Paresthesias

3 (10.0)

3 (5.4)


Psychomotor slowness

4 (13.3)

2 (3.6)


Nausea

5 (16.6)

2 (3.6)


* Fisher's Exact Test (2-tailed sig.), p < 0.05

Paparrigopoulos et al. BMC Psychiatry 2011 11:41   doi:10.1186/1471-244X-11-41

Open Data